High levels of serum hypersensitive C-reactive protein are associated with non-alcoholic fatty liver disease in non-obese people: a cross-sectional study
European Journal of Medical Research · 2024
DOI: 10.1186/s40001-024-02065-2 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift European Journal of Medical Research, 2024. Verfasst von Guitao Xia und 5 weiteren Autor:innen. Beteiligte Einrichtung: Affiliated People's Hospital of Ningbo University, Ningbo, 315040, Zhejiang Province, China. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, C-Reactive Protein. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Zhejiang Medical and Health Science and Technology Plan Project, Ningbo Natural Science Foundation, Science and Technology Project of Agriculture and Social Science of Ningbo Yinzhou District.
Abstract (Originalsprache)
INTRODUCTION: Non-alcoholic fatty liver disease (NAFLD) and obesity have become one of the most common chronic diseases, and the global prevalence is increasing year by year. Both are accompanied by hypersensitive C-reactive protein (hs-CRP). At present, there are many predictors of NAFLD. Exploring the relationship between hs-CRP and nonalcoholic fatty liver disease in non-obese people will be helpful for risk prediction and clinical screening in high-risk populations. OBJECTIVE: To explore the relationship between levels of serum hs-CRP and the presence of NAFLD in non-obese people. METHODS: A total of 6558 participants who underwent physical examination from March 2017 to November 2017. Multivariate logistic regression was utilized to analyze the risk factors associated with NAFLD. RESULTS: This study including 4240 males and 2318 females ranging from 20 to 94 years. In 1396 patients with NAFLD, the prevalence rate was 21.3%, among which 1056 (24.9%) males and 340 (14.7%) females had NAFLD. The prevalence of NAFLD was much higher in males compared to females (χ2 = 93.748, P < 0.001). In the nonalcoholic fatty liver group, various factors including hs-CRP, age, WC, BMI, systolic blood pressure and blood pressure diastolic blood pressure were significantly higher than those in the control group. Logistic regression analysis confirmed that hs-CRP was an independent risk factor for NAFLD, even after adjusting for relevant variables. CONCLUSIONS: The prevalence of NAFLD increases with the level of hs-CRP in both men and women who are non-obese. Hs-CRP levels are an important risk factor for nonalcoholic fatty liver disease in non-obese individuals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Affiliated People's Hospital of Ningbo University, Ningbo, 315040, Zhejiang Province, China.
- Affiliated People's Hospital of Ningbo University, Ningbo, 315040, Zhejiang Province, China. rmlihongliang@nbu.edu.cn.
- Affiliated People's Hospital of Ningbo University, Ningbo, 315040, Zhejiang Province, China. rmchenchangxi@nbu.edu.cn.
Förderung
- Zhejiang Medical and Health Science and Technology Plan Project
- Ningbo Natural Science Foundation
- Science and Technology Project of Agriculture and Social Science of Ningbo Yinzhou District
Zitieren
APA
Xia, G., Xu, Y., Zhang, C., Li, M., Li, H., & Chen, C. (2024). High levels of serum hypersensitive C-reactive protein are associated with non-alcoholic fatty liver disease in non-obese people: a cross-sectional study. European Journal of Medical Research. https://doi.org/10.1186/s40001-024-02065-2
Vancouver
Xia G, Xu Y, Zhang C, Li M, Li H, Chen C. High levels of serum hypersensitive C-reactive protein are associated with non-alcoholic fatty liver disease in non-obese people: a cross-sectional study. European Journal of Medical Research. 2024. doi:10.1186/s40001-024-02065-2
BibTeX
@article{Xia2024,
author = {Xia, Guitao and Xu, Yuemei and Zhang, Cheng and Li, Mengting and Li, Hongliang and Chen, Changxi},
title = {High levels of serum hypersensitive C-reactive protein are associated with non-alcoholic fatty liver disease in non-obese people: a cross-sectional study},
journal = {European Journal of Medical Research},
year = {2024},
doi = {10.1186/s40001-024-02065-2}
}
EUVIMED